Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Henri Becquerel
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients with non-small-cell lung carcinoma hitologicaly proved
Candidate patients in a treatment with aim guardian by exclusive thoracic radiotherapy or of concomitant radiochemotherapy (tumoral dose superior to 60 Gy) ( n=5 ).
Measurable tumor according to the criteria of evaluation RECIST
You may not be if
Histology other one than primitive bronchial cancer not in small cells lung
The patients for whom no tumoral target is assessable (forgiveness completes after first chemotherapy, operated patients).
Patients for whom a radiotherapy with curative aim is not indicated (tumoral extension, metastases, general state, co-morbidity).
Patient having benefited from an examination PET in the FDG with in more than 4 weeks and for which a new PET in the FDG is not necessary with in the framework of its disease
Clareo Health | Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
